Annual CFF
$477.38 M
+$666.47 M+352.46%
December 31, 2023
Summary
- As of February 12, 2025, GH annual cash flow from financing activities is $477.38 million, with the most recent change of +$666.47 million (+352.46%) on December 31, 2023.
- During the last 3 years, GH annual CFF has fallen by -$932.93 million (-66.15%).
- GH annual CFF is now -66.15% below its all-time high of $1.41 billion, reached on December 31, 2020.
Performance
GH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$2.88 M
-$8.78 M-148.91%
September 30, 2024
Summary
- As of February 12, 2025, GH quarterly cash flow from financing activities is -$2.88 million, with the most recent change of -$8.78 million (-148.91%) on September 30, 2024.
- Over the past year, GH quarterly CFF has dropped by -$6.69 million (-175.78%).
- GH quarterly CFF is now -100.28% below its all-time high of $1.05 billion, reached on December 31, 2020.
Performance
GH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$92.51 M
-$6.69 M-6.75%
September 30, 2024
Summary
- As of February 12, 2025, GH TTM cash flow from financing activities is $92.51 million, with the most recent change of -$6.69 million (-6.75%) on September 30, 2024.
- Over the past year, GH TTM CFF has dropped by -$296.62 million (-76.23%).
- GH TTM CFF is now -93.44% below its all-time high of $1.41 billion, reached on December 31, 2020.
Performance
GH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GH Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +352.5% | -175.8% | -76.2% |
3 y3 years | -66.2% | -224.5% | +148.9% |
5 y5 years | +62.8% | -224.5% | +148.9% |
GH Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +352.5% | -100.8% | +98.3% | -80.6% | +148.7% |
5 y | 5-year | -66.2% | +352.5% | -100.3% | +98.3% | -93.4% | +148.7% |
alltime | all time | -66.2% | +352.5% | -100.3% | +98.3% | -93.4% | +148.7% |
Guardant Health Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.88 M(-148.9%) | $92.51 M(-6.7%) |
Jun 2024 | - | $5.90 M(-649.2%) | $99.20 M(-79.2%) |
Mar 2024 | - | -$1.07 M(-101.2%) | $477.15 M(-0.0%) |
Dec 2023 | $477.38 M(-352.5%) | $90.57 M(+2279.0%) | $477.38 M(+22.7%) |
Sep 2023 | - | $3.81 M(-99.0%) | $389.13 M(+6.3%) |
Jun 2023 | - | $383.85 M(<-9900.0%) | $366.01 M(-292.7%) |
Mar 2023 | - | -$854.00 K(-136.8%) | -$189.94 M(+0.4%) |
Dec 2022 | -$189.09 M(+183.0%) | $2.32 M(-112.0%) | -$189.09 M(+0.8%) |
Sep 2022 | - | -$19.31 M(-88.8%) | -$187.63 M(+7.9%) |
Jun 2022 | - | -$172.09 M(>+9900.0%) | -$173.88 M(-5678.4%) |
Mar 2022 | - | -$12.00 K(-100.3%) | $3.12 M(-104.7%) |
Dec 2021 | -$66.82 M | $3.78 M(-168.0%) | -$66.82 M(-106.8%) |
Sep 2021 | - | -$5.56 M(-213.3%) | $976.12 M(-0.6%) |
Jun 2021 | - | $4.91 M(-107.0%) | $982.48 M(-26.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$69.95 M(-106.7%) | $1.34 B(-5.1%) |
Dec 2020 | $1.41 B(+284.0%) | $1.05 B(>+9900.0%) | $1.41 B(+284.6%) |
Sep 2020 | - | $797.00 K(-99.8%) | $366.66 M(-1.6%) |
Jun 2020 | - | $361.32 M(>+9900.0%) | $372.73 M(+1.7%) |
Mar 2020 | - | $1.47 M(-52.4%) | $366.48 M(-0.2%) |
Dec 2019 | $367.30 M(+25.3%) | $3.08 M(-55.2%) | $367.30 M(-40.2%) |
Sep 2019 | - | $6.87 M(-98.1%) | $614.59 M(+1.0%) |
Jun 2019 | - | $355.07 M(>+9900.0%) | $608.52 M(+106.9%) |
Mar 2019 | - | $2.29 M(-99.1%) | $294.18 M(+0.3%) |
Dec 2018 | $293.16 M(+4.1%) | $250.36 M(>+9900.0%) | $293.16 M(+585.0%) |
Sep 2018 | - | $796.00 K(-98.0%) | $42.80 M(+1.9%) |
Jun 2018 | - | $40.73 M(+3115.0%) | $42.00 M(+3215.0%) |
Mar 2018 | - | $1.27 M | $1.27 M |
Dec 2017 | $281.66 M(+607.0%) | - | - |
Dec 2016 | $39.84 M | - | - |
FAQ
- What is Guardant Health annual cash flow from financing activities?
- What is the all time high annual CFF for Guardant Health?
- What is Guardant Health annual CFF year-on-year change?
- What is Guardant Health quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Guardant Health?
- What is Guardant Health quarterly CFF year-on-year change?
- What is Guardant Health TTM cash flow from financing activities?
- What is the all time high TTM CFF for Guardant Health?
- What is Guardant Health TTM CFF year-on-year change?
What is Guardant Health annual cash flow from financing activities?
The current annual CFF of GH is $477.38 M
What is the all time high annual CFF for Guardant Health?
Guardant Health all-time high annual cash flow from financing activities is $1.41 B
What is Guardant Health annual CFF year-on-year change?
Over the past year, GH annual cash flow from financing activities has changed by +$666.47 M (+352.46%)
What is Guardant Health quarterly cash flow from financing activities?
The current quarterly CFF of GH is -$2.88 M
What is the all time high quarterly CFF for Guardant Health?
Guardant Health all-time high quarterly cash flow from financing activities is $1.05 B
What is Guardant Health quarterly CFF year-on-year change?
Over the past year, GH quarterly cash flow from financing activities has changed by -$6.69 M (-175.78%)
What is Guardant Health TTM cash flow from financing activities?
The current TTM CFF of GH is $92.51 M
What is the all time high TTM CFF for Guardant Health?
Guardant Health all-time high TTM cash flow from financing activities is $1.41 B
What is Guardant Health TTM CFF year-on-year change?
Over the past year, GH TTM cash flow from financing activities has changed by -$296.62 M (-76.23%)